Society of Infectious Diseases Pharmacists

A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).

Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, discusses how a new partnership between pharmacists and veterinarians will impact antimicrobial resistance.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, outlines factors that contribute to antimicrobial resistance and strategies to combat this threat.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, discusses how pharmacists can help decrease antibiotic use in agriculture animals.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, explains how the FDA Guidance 213 and the Veterinary Feed Directive will change the use of antibiotics for growth promotion purposes in the United States.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, discusses how collaboration with transplant counterparts is needed to provide optimal treatment.

While antibiotics serve a meaningful purpose in treating infections, appropriate use of these agents is needed in order to minimize adverse events.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, explains collaborative efforts to make up for lack of data regarding stewardship in organ transplant populations.

John Mohr, PharmD, president and founder of Medical Affairs Strategic Solutions, LLC, explains the current state of the antimicrobial pipeline.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, explains the antimicrobial considerations that are specific to the solid organ transplant population.

Emily Heil, PharmD, BCPS-AQ ID, from the University of Maryland School of Pharmacy, discusses the concerns of antibiotic use in agriculture.